Effect of Norelgestromin and Ethinylestradiol in Transdermal Patches on the Clinical Outcomes and Biochemical Parameters of COVID-19 Patients: A Clinical Trial Pilot Study

• Egile Nagusiak: Cortés-Algara Alfredo (Egilea), Cárdenas-Rodríguez Noemí (Egilea), Reyes-Long Samuel (Egilea), Ortega-Cuellar Daniel (Egilea), Ruz-Barros Rodrigo (Egilea), Mondragón-Terán Paul (Egilea), Escamilla-Tilch Mónica (Egilea), Correa-Basurto José (Egilea), Lara-Padilla Eleazar (Egilea), Alfaro-Rodríguez Alfonso (Egilea), Cortes-Altamirano José Luis (Egilea), Bandala Cindy (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2022-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

The disease caused by SARS-CoV-2 is still considered a global pandemic. Transdermal patches (TP) with immunoregulators such as estrogen and progesterone compounds could be a feasible option to treat COVID-19 because of their accessibility and relative safety. The objective of the current study was t...